수탁 연구 및 제조 서비스 시장 : 서비스 유형, 기술, 치료 영역, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Contract Research & Manufacturing Services Market was valued at USD 70.20 billion in 2024 and is projected to grow to USD 76.92 billion in 2025, with a CAGR of 9.77%, reaching USD 122.82 billion by 2030.

In the ever-changing world of contract research and manufacturing services, this executive summary provides a comprehensive overview of the current market dynamics and emerging trends that are shaping the future of the industry. The sector, which is integral to advancing biotechnology and pharmaceutical innovations, is undergoing significant transformation driven by regulatory changes, technological advancements, and a rising demand for efficient service models. In today's competitive landscape, understanding the pathways for growth and the strategic investments necessary to maintain sustainable operations is key. This report lays out the essential context that decision-makers and industry experts need while capturing the multifaceted nature of the market. The insights provided are distilled from comprehensive research and analysis, ensuring that leaders gain a robust grasp of key drivers, challenges, and opportunities. As the market increasingly leans towards integrated and innovative solutions, it becomes crucial to appreciate both the broad industry trends and the finer details underlying specialized segments. With a clear focus on the shifts that have redefined traditional protocols, this summary acts as a guiding document for stakeholders aiming to align themselves with the evolving demands of contract research and manufacturing services.

Transformative Shifts in the Landscape of Contract Research & Manufacturing Services

The contract research and manufacturing services industry has witnessed transformative shifts that extend across regulatory practices, technology adoption, and market globalization. Recent adjustments in industry standards have prompted organizations to re-evaluate their operational frameworks, leading to a surge in the adoption of advanced technologies that enhance accuracy and speed. Integration of digital solutions is creating a more interconnected environment where data-driven decision-making takes center stage. Companies are increasingly leveraging innovative processes to cut lead times, optimize resource usage, and improve compliance standards. Furthermore, the increased collaboration between sectors has fostered a climate of shared knowledge and expertise. Global market integration has also been a defining feature of this era, with emerging markets and established regions both contributing to the evolution of the service model. The combination of strategic restructuring and technology integration is not only broadening service portfolios but also streamlining research and development efforts. With the market continuously pushing the boundaries of what is possible, organizations are finding new ways to remain agile, efficient, and competitive. This moment is marked by industry players embracing change and capitalizing on opportunities that align with the digital transformation era, ultimately reshaping the global landscape.

Key Segmentation Insights Across Services, Technologies, and Applications

Detailed segmentation analysis underpins the strategic insight driving this market transformation. From a service standpoint, the industry is categorized across domains that include consulting, development, manufacturing, and research, each reflecting a unique set of challenges and growth opportunities. Exploring technology reveals segments such as bioinformatics, combinatorial chemistry, high-throughput screening, and spectroscopy, each offering distinct advancements and competitive advantages to firms investing in innovation. In a similar vein, the therapeutic area segmentation offers insights into fields like cardiovascular, endocrine disease, infectious disease, and oncology, underscoring the specialization required for successful treatment methodology development. Application-based segmentation touches on areas from biologics development and drug discovery to formulation and process development, each carved out to meet specific industry demands. Furthermore, the end user segmentation encompasses academic and research institutes, biotechnology companies, medical device companies, and pharmaceutical companies. These discussions provide a clearer perspective on where investments yield strategic returns while underscoring the nuances of demand across each segment. Understanding these diverse layers is critical for aligning operational strategies with evolving market needs and for positioning a company to better capture emerging opportunities.

Based on Service Type, market is studied across Consulting, Development, Manufacturing, and Research.

Based on Technology, market is studied across Bioinformatics, Combinatorial Chemistry, High-Throughput Screening, and Spectroscopy.

Based on Therapeutic Area, market is studied across Cardiovascular, Endocrine disease, Infectious disease, and Oncology.

Based on Application, market is studied across Biologics Development, Drug Discovery, Formulation Development, and Process Development.

Based on End User, market is studied across Academic & Research Institutes, Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.

Key Regional Insights Shaping Global Market Dynamics

The global reach of the contract research and manufacturing services industry is intricately defined by regional variances which play a crucial role in shaping the competitive landscape. The Americas, with its well-established infrastructure and robust regulatory environment, continues to generate significant innovation and investment activity. Across Europe, the Middle East, and Africa, diverse regulatory frameworks and a blend of traditional practices coupled with technological disruptions create a rich canvas for market expansion and localized expertise. Meanwhile, the Asia-Pacific region has emerged as a powerhouse of rapid growth, driven by rising investments in technology, increasing R&D capabilities, and evolving consumer demands. Each region contributes unique attributes to the overall industry narrative. By embracing the localized trends in the Americas, leveraging the creative synergies across Europe, the Middle East and Africa, and capitalizing on the dynamic potential in Asia-Pacific, organizations can tune their strategies to regional specifics. These regional insights help stakeholders identify opportunities for market entry and growth, while also providing strategic guidance on investment and operational best practices. The interplay of regional trends with industry standards continues to redefine competitive benchmarks on a global scale.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Operational Excellence

The competitive edge in contract research and manufacturing services is significantly enhanced by leading companies that continuously push the boundaries of innovation. Industry frontrunners such as AGC Biologics and Avid Bioservices, Inc. have set the stage by leveraging their expertise to drive market performance. Boehringer Ingelheim International GmbH and Cambrex Corporation consistently deliver advanced solutions while Catalent, Inc. and CHARLES RIVER LABORATORIES INTERNATIONAL, INC. remain at the forefront of both research and operational excellence. Envigo and Eurofins Scientific SE are key enablers in optimizing preclinical and analytical study processes, while Fujifilm Diosynth Biotechnologies and Gubra A/S offer innovative manufacturing scales to support diverse project demands. Strategic imprints are also left by ICON plc, IQVIA Holdings Inc., and LabCorp Drug Development, with companies such as Lonza Group Ltd and Medpace Holdings, Inc. further refining process efficiencies. Industry leaders like Parexel International Corporation and Pharmaceutical Product Development, LLC (PPD) are continually evolving their service portfolios and operational models to meet market demands. Recipharm AB, Samsung Biologics Co., Ltd., and Sartorius Stedim Biotech S.A. are instrumental in driving technological innovations that support critical product development. Organizations including Siegfried AG, Syneos Health, Inc., TFBS Bioscience Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd. round out the industry narrative with progressive strategies and robust market performances that collectively shape the competitive landscape.

The report delves into recent significant developments in the Contract Research & Manufacturing Services Market, highlighting leading vendors and their innovative profiles. These include AGC Biologics, Avid Bioservices, Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., CHARLES RIVER LABORATORIES INTERNATIONAL, INC., Envigo, Eurofins Scientific SE, Fujifilm Diosynth Biotechnologies, Gubra A/S, ICON plc, IQVIA Holdings Inc., LabCorp Drug Development, Lonza Group Ltd, Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Product Development, LLC (PPD), Recipharm AB, Samsung Biologics Co., Ltd., Sartorius Stedim Biotech S.A., Siegfried AG, Syneos Health, Inc., TFBS Bioscience Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd.. Actionable Recommendations to Propel Industry Leadership Forward

For decision-makers committed to staying ahead in the contract research and manufacturing services arena, a clear set of actionable recommendations provides a pathway to sustainable growth. First and foremost, companies should invest in technology adoption to enhance operational efficiency and speed up product development cycles. Embracing digital and data-driven solutions not only facilitates precision and quality but also fosters agile responses to shifting market demands. It is recommended to strengthen collaborations across academic, research, and industrial sectors, thereby tapping into a broader base of expertise and innovations. Furthermore, diversifying service offerings by branching into emerging segments can uncover untapped market potential, while strategically leveraging regulatory expertise ensures competitiveness across regional markets. Focusing on customization and client-focused strategies will enable organizations to deliver tailored solutions that meet unique customer requirements. Maintaining a proactive stance in trend analysis and market intelligence is essential in anticipating shifts and preparing for the future. Finally, a balanced investment in both human capital and advanced technological infrastructure will ensure that companies are well positioned to lead in an increasingly competitive global market. These recommendations are practical steps that harness the current industry momentum and prepare organizations to capitalize on forthcoming opportunities.

Conclusion: Navigating the Future With Precision and Innovation

In conclusion, the landscape of contract research and manufacturing services is characterized by dynamic shifts and a multitude of emerging opportunities. The industry's evolution, powered by technological innovations, regulatory advancements, and strategic diversification, offers significant prospects for those who are agile and forward-thinking. A careful examination of segmentation, from service and technology to therapeutic areas and end-user demands, reveals intricate nuances that require dedicated focus for strategic decision-making. Furthermore, the delineation of global regions showcases how localized market dynamics integrate into a cohesive global narrative. Underpinned by the robust performance of leading companies, the market continues to thrive, driven by innovations and strategic partnerships that enhance efficiency and productivity. The insights presented here underscore the need for a proactive, well-informed approach to navigate regulatory shifts, integrate cutting-edge technologies, and unlock sustainable growth. As the industry stands on the cusp of further evolution, firms that invest in strategic operations and continuous improvement are best positioned to seize upcoming opportunities and transform challenges into competitive advantages.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased outsourcing of research and development activities
    • 5.1.1.2. Growing demand for personalized treatments and precision medicine
    • 5.1.1.3. Rising regulatory requirements necessitating robust quality control measures
  • 5.1.2. Restraints
    • 5.1.2.1. High operational costs and complex regulatory compliance
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in digital technologies and data analytics
    • 5.1.3.2. Enhanced supply chain management solutions to streamline logistics and reduce operational costs
  • 5.1.4. Challenges
    • 5.1.4.1. Risks related to intellectual property protection & data security
• 5.2. Market Segmentation Analysis
  • 5.2.1. Service Type: Increasing preference of consulting services owing to technological innovations
  • 5.2.2. Application: Expanding application of contract research manufacturing services in drug discovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Contract Research & Manufacturing Services Market, by Service Type

• 6.1. Introduction
• 6.2. Consulting
• 6.3. Development
• 6.4. Manufacturing
• 6.5. Research

7. Contract Research & Manufacturing Services Market, by Technology

• 7.1. Introduction
• 7.2. Bioinformatics
• 7.3. Combinatorial Chemistry
• 7.4. High-Throughput Screening
• 7.5. Spectroscopy

8. Contract Research & Manufacturing Services Market, by Therapeutic Area

• 8.1. Introduction
• 8.2. Cardiovascular
• 8.3. Endocrine disease
• 8.4. Infectious disease
• 8.5. Oncology

9. Contract Research & Manufacturing Services Market, by Application

• 9.1. Introduction
• 9.2. Biologics Development
• 9.3. Drug Discovery
• 9.4. Formulation Development
• 9.5. Process Development

10. Contract Research & Manufacturing Services Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Biotechnology Companies
• 10.4. Medical Device Companies
• 10.5. Pharmaceutical Companies

11. Americas Contract Research & Manufacturing Services Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Contract Research & Manufacturing Services Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Contract Research & Manufacturing Services Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Aragen secures USD 100 million investment from Quadria Capital to increase R&D, infrastructure, and global service offerings
  • 14.3.2. Thermo Fisher launches accelerator drug development platform amid strategic expansions and integrated CDMO and CRO services
  • 14.3.3. SK Pharmteco invests USD 260 million in a 136,000-square-foot facility in Sejong to drive global manufacturing expansion
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AGC Biologics
• 2. Avid Bioservices, Inc.
• 3. Boehringer Ingelheim International GmbH
• 4. Cambrex Corporation
• 5. Catalent, Inc.
• 6. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
• 7. Envigo
• 8. Eurofins Scientific SE
• 9. Fujifilm Diosynth Biotechnologies
• 10. Gubra A/S
• 11. ICON plc
• 12. IQVIA Holdings Inc.
• 13. LabCorp Drug Development
• 14. Lonza Group Ltd
• 15. Medpace Holdings, Inc.
• 16. Parexel International Corporation
• 17. Pharmaceutical Product Development, LLC (PPD)
• 18. Recipharm AB
• 19. Samsung Biologics Co., Ltd.
• 20. Sartorius Stedim Biotech S.A.
• 21. Siegfried AG
• 22. Syneos Health, Inc.
• 23. TFBS Bioscience Inc.
• 24. Thermo Fisher Scientific Inc.
• 25. WuXi AppTec Co., Ltd.